INTRODUCTION: Hypothyroidism (HT) has been found a predictor of cardiovascular diseases. We aimed to ascertain the prevalence of HT in patients with manifest coronary heart disease (CHD), and to establish its association with conventional risk factors. METHODS: 410 patients, 6-24 months after hospitalization for acute coronary syndrome, and/or revascularization, were included into the cross-sectional study. RESULTS: The prevalence of thyroid dysfunction was found in males and females as follows: overt HT, ie, thyroid stimulating hormone (TSH) > 3.65 mIU/L and free thyroxine (fT4) < 9 pmol/L and/or L-thyroxine substitution, in 2.6% and 8.4%, respectively; subclinical HT (TSH > 3.65, fT4 9-23 and no substitution) in 4.3% and 15.0%, respectively. Higher prevalence of HT was found in females with hypercholesterolemia, and in males and females with concomitant positive thyroid peroxidase antibodies. Hypothyroid subjects had higher total homocysteine in both genders and von Willebrand factor in males only. Hypothyroid females had higher total and LDL cholesterol, and were more often treated for diabetes. CONCLUSIONS: HT was found highly prevalent in patient with clinical coronary heart disease, mainly in females, and was associated with several cardiovascular risk factors.

Center of Preventive Cardiology 2nd Department of Internal Medicine Charles University Medical Faculty Plzen Czech Republic

Zobrazit více v PubMed

Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13:3–126. PubMed

Becker C. Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev. 1985;6:432–40. PubMed

Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526–34. PubMed

Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab. 2002;87:1533–8. PubMed

Cimino JA, Jhangiani S, Schwarz E, et al. Riboflavin metabolism in the hypothyroid human adult. Proc Soc Exp Biol Med. 1987;184:151–3. PubMed

Christ-Crain M, Meier C, Guglielmetti M, et al. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis. 2003;166:379–86. PubMed

Danese MD, Ladenson PW, Meinert CL, et al. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature. J Clin Endocrinol Metab. 2000;85:2993–3000. PubMed

Duckworth WC, Badlissi J, Kitabchi AE. Thyroid function in diabetes. In: Vanmiddleworth L, editor. The thyroid gland. Chicago: Year Book Medical; 1986. pp. 247–61.

Hak AE, Pols HAP, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women. The Rotterdam study. Ann Intern Med. 2000;132:270–8. PubMed

EUROASPIRE II Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II. Eur Heart J. 2001;22:554–72. PubMed

Flynn RW, MacDonald TM, Jung RT, et al. Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab. 2006;91:2159–64. PubMed

Gartner W, Weissel M. Do iodine-containing contrast media induce clinically relevant changes in thyroid function parameters of euthyroid patients within the first week? Thyroid. 2004;14:521–4. PubMed

Gray RS, Irvine WJ, Clarke BF. Screening for thyroid dysfunction in diabetics. Br Med J. 1979;2:1439. PubMed PMC

Hollowell J, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) J Clin Endocrinol Metab. 2002;87:489–99. PubMed

Kreisman SH, Hennessey JV. Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med. 1999;159:79–82. PubMed

Mayer O, Jr, Simon J, Hrbkova J, et al. Epidemiological study of hypothyroidism as cardiovascular risk in population. Cas Lek Cesk. 2005;144:459–64. PubMed

Meier C, Staub JJ, Roth CB, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels, clinical symptoms in subclinical hypothyroidsm? A double blind, placebo-controlled trial (Basel Thyroid Study) J Clin Endocrinol Metab. 2001;86:4860–6. PubMed

Perros P, McCrimmon RJ, Shaw G, et al. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995;12:622–7. PubMed

Rivlin RS, Landon RG. Regulation of hepatic FAD levels by thyroid hormone. Adv Enzyme Regul. 1966;4:45–58. PubMed

Rochon C, Tauveron I, Dejax C. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci. 2003;104:7–15. PubMed

Samuel MH. Subclinical thyroid disease in the elderly. Thyroid. 1998;8:803–13. PubMed

Scarbottolo L, Trezze E, Roma P, et al. Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liver. Atherosclerosis. 1986;59:329–33. PubMed

Shane B, Stokstad EL. Vitamin B12–folate interrelationships. Ann Rev Nutr. 1985;5:115–41. PubMed

Taddei S, Caraccio N, Virdis A, et al. Impaired endothelium-dependent vasadilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab. 2004;88:3731–7. PubMed

Thomson GR, Souter AK, Spengel FA, et al. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sc USA. 1981;78:2591–5. PubMed PMC

Umpierrez GE, Kashif AL, Murphy MB. Thyroid dysfunction in patients with Type 1 Diabetes A longitudinal study. Diabetes Care. 2003;26:1181–5. PubMed

Vanderpump MPJ, Tunbridge WMG. The epidemiology of thyroid disease. In: Braveman LE, Utiger RD, editors. The Thyroid. 9th ed. Piladelphia: Lippincott-Raven Publisher; 1996. pp. 474–82.

Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J. 2002;325:1202–6. PubMed PMC